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Aims. Timely recognition and treatment of mental disorders with an onset in childhood and 
adolescence is paramount, as these are characterized by greater severity and longer persistence than 
disorders with an onset in adulthood. Studies examining time-to-treatment, also referred to as 
treatment delay, duration of untreated illness or latency to treatment, and defined as the time 
between disorder onset and initial treatment contact, are sparse and all based on adult samples. The 
aim of this study was to describe time-to-treatment and its correlates for any health care 
professional (any care) and secondary mental health care (secondary care), for a broad range of 
mental disorders, in adolescents. 
Methods. Data from the Dutch community-based cohort study TRacking Adolescents’ Individual Lives 
Survey (TRAILS; N=2230) were used. The Composite International Diagnostic Interview (CIDI) was 
administered to assess DSM-IV disorders, the age of onset, and the age of initial treatment contact 
with any health care professional in 1584 adolescents of 18-20 years old. In total 43% of the 
adolescents (n=675) were diagnosed with a lifetime DSM-IV disorder. The age of initial treatment 
contact with secondary care was based on administrative records from 321 adolescents without a 
disorder onset before the age of 10. Descriptive statistics, cumulative lifetime probability plots, and 
Cox regression analyses were used analyze time-to-treatment. 
Results. The proportion of adolescents who reported lifetime treatment contact with any care varied 
from 15% for alcohol dependence to 82% for dysthymia. Regarding secondary care, proportions of 
lifetime treatment contact were lower for mood disorders and higher for substance dependence. 
Time-to-treatment for any care varied considerably between and within diagnostic classes. The 
probability of lifetime treatment contact for mood disorders was above 90%, whereas for other 
mental disorders this was substantially lower. An earlier age of onset predicted a longer, and the 
presence of a co-morbid mood disorder predicted a shorter time-to-treatment in general. Disorder 
severity predicted a shorter time-to-treatment for any care, but not for secondary care. Time-to-




treatment for secondary care was shorter for adolescents from low and middle socioeconomic 
background than for adolescents from a high socioeconomic background. 
Conclusions. Although the time-to-treatment was shorter for adolescents than for adults, it was still 
substantial, and the overall patterns were remarkably similar to those found in adults. Efforts to 
reduce time-to-treatment should therefore be aimed at children and adolescents. Future research 
should address mechanisms underlying time-to-treatment and its consequences for early-onset 
disorders in particular. 
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The prevalence of mental disorders is high (Kessler et al. 2005a; Moffitt et al. 2010; de Graaf et al. 
2012). Although mental disorders are associated with a tremendous disease burden (Whiteford et al. 
2013), worldwide, no more than one-third of people with a mental disorder receive treatment 
(Kessler et al. 2005b; Thornicroft 2012). The majority of mental disorders in adulthood have their 
onset in adolescence and early adulthood (Wang et al. 2005; Kessler et al. 2007; Merikangas et al. 
2010; de Girolamo et al. 2012; Ormel et al. 2015), and interfere with key areas of development such 
as education, social relationships, and the transition to work (Costello & Maughan 2015). Timely 
recognition and treatment of such early-onset mental disorders is paramount, as these are 
characterized by greater severity and longer persistence than disorders with an onset in adulthood 
(Kessler et al. 1998; Korczak & Goldstein 2009; Reef et al. 2010). However, despite the apparent need 
for care (Jörg et al. 2015), only a small proportion of youths actually receive timely treatment 
(Merikangas et al. 2011; de Girolamo et al. 2012; Jansen et al. 2013). 
Studies focusing on the time between the onset of a mental disorder and initial treatment contact 
(time-to-treatment; also referred to as treatment delay, duration of untreated illness or latency to 
treatment), have mainly focused on the duration of untreated psychosis (DUP). Review studies show 
that a longer DUP is associated with a worse course of illness and worse outcomes (Marshall et al. 
2005; Perkins et al. 2005). Studies focusing on time-to-treatment in common mental disorders are 
sparse (Ghio et al. 2014), but these also point towards poorer outcomes of disorders with longer 
time-to-treatment (Kisely et al. 2006; Dell’Osso & Altamura 2010). Of particular interest is the finding 
that an earlier age of onset is associated with a longer time-to-treatment in both community (Kessler 
et al. 1998; Christiana et al. 2000; Wang et al. 2004, 2005, 2007; Bruffaerts et al. 2007; Korczak & 
Goldstein 2009; ten Have et al. 2013a) and clinical samples (Altamura et al. 2007, 2008). Although 
these studies generally stress the importance of recognition and treatment of early-onset disorders 
in the critical age range of 10-24 years, they are all based on adult samples. 




Our aim is to expand on the available literature by describing time-to-treatment and its correlates for 
any health care professional (hereafter referred to as any care) and secondary mental health care 
(hereafter referred to as secondary care), for a broad range of mental disorders, in adolescents. We 
will use data from the Dutch Tracking Adolescents’ Individual Lives Survey (TRAILS), a large 
community-based cohort study in which participants were followed from childhood into emerging 
adulthood (Oldehinkel et al. 2015), to do so. The Composite International Diagnostic Interview (CIDI) 
(Kessler & Üstün 2004) was administered to establish age of onset of mental disorders as well as age 
of initial treatment contact with any care. Furthermore, data from the Psychiatric Case Register 





The data used in this study were from the Tracking Adolescents’ Individual Lives Survey (TRAILS), a 
prospective population-based cohort study aimed at explaining the development of mental health 
from early adolescence into adulthood. The TRAILS sample, response rates, and study contents have 
been described in detail elsewhere (de Winter et al. 2005; Nederhof et al. 2012; Oldehinkel et al. 
2015). In short, after the exclusion of children whose schools refused participation (n=338), and 
children with serious mental or physical health problems or language difficulties (n=210), consent to 
participate in the study was obtained from 2230 (76.0%) out of 2935 eligible children and their 
parents. Teacher-reported levels of psychopathology did not differ between responding and non-
responding children, but boys, children with a lower socioeconomic background, and children with 
relatively poorer school performance were more likely to be non-responders (de Winter et al. 2005). 




We used data from the first and fourth assessment wave, which ran from March 2001 to July 2002 
(T1), and from October 2008 to September 2010 (T4). Of the T1 participants (mean age=11.1 years, 
SD=0.6 years, 50.8% girls), 84.3% still participated at T4 (n=1881, mean age=19.1 years, SD=0.6 years, 
52.3% girls). Drop-out was related to being male, low intelligence, low educational level, low parental 
socioeconomic position, single-parent families, being bullied, and parent-reported behavior problems 
(Nederhof et al. 2012). As part of T4, the CIDI was completed by 1584 adolescents (response 
rate=71.0%, mean age=19.3 years, SD=0.6 years, 54.0% girls) (Ormel et al. 2015). 
The TRAILS data were linked to the Psychiatric Case Register North Netherlands (PCRNN; hereafter 
referred to as the register), which covers secondary child, adolescent and adult mental health care 
organizations. The catchment area of the register covers 1.7 million inhabitants, and overlaps with 
the geographic area from which TRAILS participants were recruited. The register, which contained 
data from 2000 onward, did not include primary (youth) mental health care, private practices, and 
commercial mental health care organizations. Consent to link the TRAILS database to the register was 
obtained from 1385 CIDI participants and their parents (87.4%). A 95% likelihood matching 
procedure uniquely identified 342 children with one or more records in the PCRNN (24.7%). 
 
Measures 
Lifetime prevalence, age of onset, and age of initial treatment contact of DSM-IV disorders (American 
Psychological Association 1994) were established using the World Mental Health Organization (WHO) 
Composite International Diagnostic Interview (CIDI) version 3.0 (Kessler & Üstün 2004), a structured 
diagnostic interview that can be administered by trained lay interviewers. Clinical reappraisal studies 
showed generally good validity of CIDI diagnoses when compared to blinded clinical reappraisal 
interviews (Haro et al. 2006; Kessler et al. 2009). Disorders included in this study were mood 
disorders (major depressive disorder [MDD], dysthymic disorder [DYS], and bipolar disorder types I 
and II [BPD]); anxiety disorders (separation anxiety disorder [SAD], agoraphobia without panic 




disorder [AGP], generalized anxiety disorder [GAD], obsessive-compulsive disorder [OCD], panic 
disorder [PDS], social phobia [SO], and specific phobia [SP]); behavior disorders (attention deficit 
hyperactivity disorder [ADHD], and oppositional defiant disorder [ODD]); and substance dependence 
(alcohol dependence [ALD], and drug dependence [DRD]). Organic exclusion criteria, for disorders 
caused by physical illness, and diagnostic hierarchy rules, for disorders better explained by other 
disorders, were used where applicable. 
Time-to-treatment was defined as the time in years between the age of onset, which is the age at 
which all DSM-IV diagnostic criteria for the index disorder were met for the first time, and the age of 
initial treatment contact. The age of initial treatment contact was established in two different ways: 
with regard to any care as assessed by the CIDI, and with regard to secondary care based on the 
register. In the CIDI, respondents were asked in each diagnostic section separately whether they had 
ever talked about the symptoms of the index disorder with a medical doctor or any other health care 
professional, such as psychologists, clergymen, herbalists, and acupuncturists. If acknowledged, 
respondents were asked their age at first contact. For respondents with a record in the register, the 
age of initial treatment contact in secondary care was determined based on the date of the first 
entry in the register. Thus, in case of multiple disorders, the age of initial treatment contact could 
differ by disorder for any care, while it would be the same for all disorders for secondary care. 
The predictor variables included sex (male; female), ethnic minority status (at least one parent born 
in a non-developed country; both parents born in a developed country), intelligence (IQ<85; 
85≤IQ≤115; IQ>115) (Silverstein 1975), parental socioeconomic position (SEP; lowest 25%; 
intermediate 50%; highest 25%) (Amone-P’Olak et al. 2010), number of biological parents in the 
household (none or one; two), disorder severity (mild; severe) (Merikangas et al. 2010; Ormel et al. 
2015), age at onset (1-5; 6-10; 11-15; 16-20), and presence of a co-morbid disorder from another 
diagnostic class (no; yes). Intelligence, parental SEP, and number of biological parents in the 
household were assessed at T1. A disorder was considered severe if it exceeded, at any time, the 




impairment or distress thresholds required for the regular CIDI DSM-IV disorders. Co-morbidity was 
included as a time-varying covariate for each diagnostic class separately. 
 
Analyses 
For the analyses, only participants with a CIDI DSM-IV diagnosis were included, which amounted to 
42.6% of all CIDI participants (n=675). Although seemingly high, according to Ormel et al. (2015) the 
prevalence rates found in TRAILS are comparable to those found in similar studies. Results from 
prospective studies suggest actual lifetime prevalence rates are even higher (Moffitt et al. 2010), and 
that emotional and behavioral problems are nearly universal in nature (Angst et al. 2016). Of the CIDI 
participants with consent to link their data to the register (n=1385), 23.2% (n=321) were included 
because their first disorder had an onset since 2000, whereas 19.5% (n=270) were excluded because 
of a disorder onset before 2000. Cases with a disorder onset before 2000 were more often identified 
in the register (38% vs 26%, χ12=9.7, p<.002), and more often had disorders from multiple diagnostic 
classes (47% vs 28%, χ12=25.4, p<.001) than cases with a disorder onset since 2000. 
The main analyses were divided into two parts. First, time-to-treatment was described using 
observed proportions of adolescents who made treatment contact at any point in their lives, 
subdivided into three groups: after initial symptoms and before, in, and after the year of onset of the 
full-blown disorder. Furthermore, cumulative probability curves of lifetime treatment contact were 
estimated using survival analysis. These curves were generated for each disorder separetely using 
survival analysis, and showed the estimated cumulative proportion of cases that eventually make 
treatment contact. The actuarial method was used, because it is better suited than the Kaplan-Meier 
method for events for which the period rather than the exact date during which an event has 
occurred is known (c.f. Wang et al. 2005; Bunting et al. 2012). The results were weighted by sex, the 
Child Behavior Checklist total problems score (Achenbach & Rescorla 2001), and parental SEP to 
account for selective non-response (Ormel et al. 2015). Second, Cox regression analyses (Kleinbaum 




& Klein 2012) were used to test predictors of time-to-treatment for the four diagnostic classes, and 
any disorder. Cases without treatment contact were censored at the age of the interview. The 
analyses were performed separately for any care and for secondary care. 
Aditionally, we performed two sensitivity analyses on the data regarding any care. First, the Cox 
regression analyses were repeated while excluding cases with any disorder onset before 2000. This 
exclusion criterium was also used in the analyses regarding secondary care . Second, the Cox 
regression analyses for disorder classes were repeated using treatment for any disorder rather than 
disorder-specific treatment, because the register data could not be linked to any specific disorder 
class. 
All analyses were performed with SPSS 23.0 (IBM Corp. 2015). 
 
Results 
Table 1 shows the proportions of lifetime treatment contact, subdivided into treatment contact after 
initial symptoms and before, in, and after the year of onset of the full-blown disorder, for any any 
care and secondary care, among adolescents with a mental disorder according to the CIDI. The 
proportion of adolescents with a mental disorder who had lifetime treatment contact with any care 
by the age of 18-20 varied between 15% for alcohol dependence and 82% for dysthymia. Lifetime 
treatment rates for secondary care were considerably lower for mood disorders, and higher for 
substance dependence compared to any care. Notably, for secondary care the proportions of cases 
with treatment contact before onset of the full-blown disorder were higher than for any care. 
 
***** Table 1 about here ***** 
 




Figure 1 shows for each disorder separately the estimated cumulative proportions of adolescents 
who will eventually make treatment contact. Three observations stood out. First, the curves showed 
much variation. For mood (figure 1A) and behavior disorders (figure 1C), the curves were comparable 
within their class, but differed markedly from the other class. The curves for anxiety disorders (figure 
1B) showed much within-class variation. Curves for substance dependence (figure 1D) resembled 
those for behavior disorders. Second, disorders with a high probability of treatment contact, such as 
major depression and generalized anxiety, typically had distinctly higher proportions of initial 
treatment contact in the first years after onset than disorders with a low probability of treatment 
contact, such as separation anxiety and specific phobia. Third, time-to-treatment was substantial. 
Time-to-treatment was shortest for mood disorders, yet the cumulative probability of treatment 
contact at two years after onset was only 50%. A cumulative probability of treatment contact of 50% 
for anxiety and behavior disorders was only reached 17 and 12 years after onset respectively. 
 
***** Figure 1 about here ***** 
 
Results from the Cox regression analyses predicting time-to-treatment are shown in tables 2 (any 
care) and 3 (secondary care). Age of onset predicted time-to-treatment for any disorder for both any 
care and secondary care. When a disorder had an earlier onset, the time-to-treatment was longer. 
Models analyzing each of the disorder classes separately showed similar effects, although the effects 
were mostly non-significant for secondary care. Co-morbidity predicted time-to-treatment only in six 
out of the 32 possible associations reported in tables 2 and 3; a co-morbid mood disorder in 
particular predicted a shorter time-to-treatment. Disorder severity predicted shorter time-to-
treatment with any care, while it was not associated with secondary care. The effect of parental 
socioeconomic position (SEP) showed a trend towards shorter time-to-treatment for secondary care 




for adolescents with parents from a low or middle SEP compared to adolescents with parents from a 
high SEP. 
 
***** Table 2 about here ***** 
 
***** Table 3 about here ***** 
 
Two sensitivity analyses for any care were performed (available as online supplementary material). 
When excluding adolescents with any disorder onset before 2000 (appendix table 1), age at onset 
effects were often no longer statistically significant, although hazard ratios remained similar, and 
disorder severity no longer significantly predicted a shorter time-to-treatment for anxiety and 
behavior disorders. When considering any treatment contact rather than disorder-specific treatment 
contact (appendix table 2), co-morbidity more often predicted a shorter time-to-treatment. 
 
Conclusion 
The time-to-treatment with any care for adolescents varied considerably across disorders, but was 
substantial even for mood disorders, which in general showed the shortest time-to-treatment. Cox 
regression analyses showed that the time-to-treatment was longer as the onset was earlier. 
Furthermore, the time-to-treatment was shorter for severe compared to mild disorders, and for 
disorders with a co-morbid mood disorder. These results were replicated for secondary care, with 
the exception that disorder severity was not related to time-to-treatment. 
 





The results need to be interpreted considering three limitations. The first limitation is recall bias (e.g. 
Wang et al. 2005; Altamura et al. 2010). Respondents may forget about or downplay mental health 
problems for which they did not seek treatment, which would lead to overestimated proportions of 
treatment contact. Recall bias may also cause respondents to remember past events as more recent 
than they actually took place (telescoping). Since onset usually occurs years before initial treatment 
contact, the probability of telescoping is likely larger for age of onset than for age of initial treatment 
contact. The time-to-treatment is therefore possibly underestimated. Our study, however, had two 
advantages over previous studies (Wang et al. 2004; Bruffaerts et al. 2007; Bunting et al. 2012; ten 
Have et al. 2013a), which probably limited recall bias. First, the diagnostic interview was 
administered at the age of 18-20 years rather than up to 60 years and older, so the recall period was 
much shorter than in previous studies. Second, administrative records are considered more reliable 
than self-reported treatment seeking (Wang et al. 2004; Olfson et al. 2012). 
The second limitation is that most predictors of time-to-treatment were not assessed over time. 
Intelligence, parental SEP, and the number of biological parents in the household were only assessed 
when the participants were 10-12 years old. For the majority of adolescents, however, these are 
likely to be stable factors. Furthermore, disorder severity could only be assessed lifetime, rather than 
at the moment of initial treatment contact. Therefore, assuming symptom recognition and treatment 
seeking are more likely when disorders are severe than when they are mild (Merikangas et al. 2011; 
ten Have et al. 2013b) the effect of disorder severity on time-to-treatment could have been 
underestimated. 
The third limitation of this study concerns the coverage of the PCRNN. First, this register does not 
cover primary (youth) mental health care, private practices, and commercial mental health care 
organizations. Nevertheless, the register still covers an estimated 75% of all mental health treatment 
trajectories for children and adolescents in secondary care (Jörg et al. 2015). Second, this register 




does not include data prior to 2000, which corresponds approximately to the age of ten in our 
sample. Both lead to an underestimation of the proportion of secondary care users. Additionally, 
time-to-treatment for secondary care is likely to be underestimated considerably, because cases with 
early-onset disorders, who typically had the longest time-to-treatment, had to be excluded from the 
secondary care analyses. 
 
Time-to-treatment 
A comparison between our findings on time-to-treatment for mental disorders in adolescents and 
prior studies conducted in adults yields two main observations. First, the time-to-treatment was 
shorter in our adolescent sample than in comparable adult samples (Wang et al. 2004, 2005, 2007; 
Bruffaerts et al. 2007; ten Have et al. 2013a). However, estimates of time-to-treatment are highly 
dependent on follow-up time, which was substantially shorter in our sample of adolescents than in 
the adult samples. Second, the patterns of time-to-treatment in adolescents are remarkably similar 
to those found in Dutch (ten Have et al. 2013a), Belgian (Bruffaerts et al. 2007), Northern Irish 
(Bunting et al. 2012), and American (Wang et al. 2005) adults. For instance, mood disorders are 
characterized by high proportions of lifetime treatment contact and a relatively short time-to-
treatment in all ages, while within the class of anxiety disorders initial treatment contact is made 
most and fastest for panic disorder, and least and slowest for specific phobia. Although differences 
among countries do exist (Wang et al. 2007), we expect to find highly similar patters of time-to-
treatment in adolescents from other countries as well. 
 
Predictors of time-to-treatment 
Following studies using adult community samples (Kessler et al. 1998; Wang et al. 2004, 2005, 2007; 
Bruffaerts et al. 2007; Korczak & Goldstein 2009; ten Have et al. 2013a), we found that time-to-




treatment is longer when disorders have an onset earlier in life. We were able to confirm a robust 
association between earlier onset and a longer time-to-treatment. An important reason for this age 
of onset-effect is that children’s access to mental health care depends on recognition and help-
seeking by their parents or teachers (Wang et al. 2005; Bruffaerts et al. 2007; ten Have et al. 2013a). 
Symptoms from early-onset disorders may not be recognized because they may be considered as 
being a part of a childs identity, are not severe enough, or are not disturbing enough to the social 
environment (Wang et al. 2005; ten Have et al. 2013a; Jörg et al. 2015), potentially resulting in 
unmet need. The development of coping strategies may mitigate or even eliminate the need for 
treatment, at least in the short term, until adolescents enter a life phase during which they have to 
be more self-reliant. In adults, early-onset disorders have been associated with a time-to-treatment 
of decades (Kessler et al. 1998; Christiana et al. 2000; Wang et al. 2004, 2005; Bunting et al. 2012). 
This at least raises the questions of how potentially harmful a long time-to-treatment for early-onset 
disorders is, and whether prevention and early intervention programs aimed specifically at children 
and adolescents should be employed (Merikangas et al. 2010; Bunting et al. 2012; de Girolamo et al. 
2012; Thornicroft 2012; Ghio et al. 2014). 
The current study added to the literature by including severity and co-morbidity as predictors of 
time-to-treatment. Co-morbid mood disorders most often predicted shorter time-to-treatment, but 
co-morbidity from other classes was mostly unrelated to time-to-treatment for any care. Maybe only 
co-morbid disorders with a short time-to-treatment themselves, such as dysthymia and panic 
disorder, accelerate the time-to-treatment for other disorders, as opposed to for instance social and 
specific phobia (Olfson et al. 2012). Alternatively, perhaps the onset of a co-morbid disorder prompts 
treatment seeking for the co-morbid disorder, rather than for the index disorder (Chapman et al. 
2015). That co-morbidity tended to be a stronger predictor for secondary care than for any care, was 
probably because treatment contact in secondary care could not be attributed to any disorder in 
particular. 




Disorder severity, operationalized in this study as high levels of impairment or distress, predicted 
shorter time-to-treatment for any care. This is largely in line with a previous finding that symptoms of 
functional impairment predicted shorter time-to-treatment for alcohol dependence, whereas the 
number of dependence symptoms did not (Chapman et al. 2015). Unexpectedly, disorder severity 
was not associated with time-to-treatment for secondary care. Adolescents whose first disorder had 
an onset aproximately before the age of 10 did not have a severe disorder more often than did 
adolescents whose first disorder had an onset later in life. They did have treatment contact with 
secondary care more often, and they showed more signs of multimorbidity. This might indicate that 
the time-to-treatment with secondary care is reduced by the complexity of psychopathology, rather 
than the levels of impairment or distress. 
 
Secondary care 
The results for secondare care were largely similar to those for any care. The sensitivity analyses for 
any care shared many characteristics with the Cox regression analyses for secondary care, and lead 
to the same substantive conclusions. We therefore think that the latter suffered from reduced 
statistical power, but not reduced precision of estimates. 
An interesting finding was that time-to-treatment for secondary care was shorter for adolescents 
from a low or middle than for adolescents from a high socioeconomic background, while no such 
pattern was found for any care. As a high socioeconomic background has been associated with more 
parent reported specialist mental health care use (Amone-P’Olak et al. 2010), parents from a high 








This study is, as far as we know, the first to describe time-to-treatment and its correlates for lifetime 
mental disorders in a large cohort of adolescents. The differentiation between any care and 
secondary care, and the inclusion of disorder severity and co-morbidity as predictors of time-to-
treatment add further relevance to this study. Time-to-treatment is already substantial in 
adolescence, and shows patterns highly similar to those observed in adult samples, which confirms 
the importance of focusing on childhood and adolescence for the reduction of time-to-treatment. 
Next to age of onset, only disorder severity and co-morbidity are consistently related to time-to-
treatment. This suggests that the characteristics of psychopathology are more important correlates 
of time-to-treatment than the background variables that are generally included yet hardly produce 
consistent findings, such as family characteristics. For a better comprehension of time-to-treatment, 
future studies should ideally address theoretical explanations of time-to-treatment, such as parental 
recognition, coping, and unmet need, as well as the outcomes of time-to-treatment, such as social 
functioning and educational attainment. 
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Table 1. Weighteda lifetime treatment contact, sibdivided into initial treatment contact after initial symptoms and before, in, or after the year of onset of the full-blown disorder. The left part of the table 
shows treatment contact with any health care professionalb for all adolescents with a DSM-IV disorder. The right part of the table shows treatment contact with secondary mental health carec for 
adolescents with a DSM-IV disorder but without any disorder onset before 2000 
  
Initial treatment contact with any health care 
professionalb for all adolescents with a full-blown 
DSM-IV disorder 
 Initial treatment contact with secondary mental 
health carec for adolescents with a full-blown DSM-IV 




















n % (S.E.) % (S.E.) % (S.E.) % (S.E.) 
 
n % (S.E.) % (S.E.) % (S.E.) % (S.E.) 
Mood disorders            
 Bipolar disorder 13 55.4 (10.5) 4.3 (4.3) 21.9 (8.7) 29.1 (9.6)  3 39.5 (19.2) 27.4 (17.5) 0.0 (0.0) 12.1 (12.9) 
 Major depressive disorder 159 64.5 (3.1) 7.1 (1.6) 23.4 (2.7) 33.9 (3.0)  48 34.5 (4.0) 10.7 (2.6) 4.6 (1.8) 19.3 (3.3) 
 Dysthymia 22 81.7 (7.5) 14.6 (6.9) 26.3 (8.6) 40.9 (9.6)  1 14.1 (14.4) 0.0 (0.0) 0.0 (0.0) 14.1 (14.4) 
 Any mood disorder 175 63.8 (2.9) 7.2 (1.6) 23.4 (2.6) 33.3 (2.9)  51 34.5 (3.9) 11.5 (2.6) 4.3 (1.7) 18.8 (3.2) 
Anxiety disorders            
 Separation anxiety disorder 10 22.5 (6.2) 0.0 (0.0) 10.5 (4.5) 12.0 (4.8)  5 39.4 (15.0) 21.9 (12.7) 8.8 (8.7) 8.8 (8.7) 
 Agoraphobia without panic disorder 6 37.8 (12.8) 0.0 (0.0) 18.5 (10.3) 19.3 (10.4)  2 65.9 (34.2) 0.0 (0.0) 34.9 (34.4) 31.0 (33.4) 
 Generalized anxiety disorder 27 58.1 (7.4) 6.5 (3.7) 21.3 (6.1) 30.3 (6.9)  9 43.9 (11.5) 19.8 (9.2) 14.3 (8.1) 9.8 (6.9) 
 Obsessive-compulsive disorder 28 30.2 (4.8) 0.0 (0.0) 7.6 (2.7) 22.6 (4.3)  11 28.9 (7.5) 13.7 (5.7) 2.4 (2.5) 12.8 (5.5) 
 Panic disorder 11 43.0 (9.9) 0.0 (0.0) 35.5 (9.6) 7.6 (5.3)  4 45.7 (17.8) 22.9 (15.0) 0.0 (0.0) 22.8 (15.0) 
 Social phobia 68 34.6 (3.4) 0.0 (0.0) 4.7 (1.5) 29.9 (3.3)  21 22.3 (4.3) 5.0 (2.3) 0.9 (1.0) 16.3 (3.9) 
 Specific phobia 44 24.1 (3.2) 0.0 (0.0) 2.8 (1.2) 21.4 (3.1)  10 31.2 (8.4) 2.6 (2.9) 3.1 (3.2) 25.5 (7.9) 
 Any anxiety disorder 152 34.6 (2.3) 0.0 (0.0) 5.7 (1.1) 28.9 (2.2)  46 27.3 (3.4) 8.9 (2.2) 1.6 (1.0) 16.8 (2.9) 
Behavior disorders            
 Attention deficit disorder 37 56.5 (6.2) 3.4 (2.3) 6.3 (3.1) 46.8 (6.2)  2 100.0 (0.0) 62.8 (40.4) 0.0 (0.0) 37.2 (40.4) 
 Oppositional defiant disorder 58 41.7 (4.2) 5.0 (1.9) 12.1 (2.8) 24.6 (3.7)  17 38.3 (7.4) 7.0 (3.9) 5.5 (3.5) 25.8 (6.7) 
 Any behavior disorder 82 45.9 (3.7) 4.6 (1.6) 9.9 (2.2) 31.4 (3.5)  19 41.5 (7.3) 9.9 (4.4) 5.3 (3.3) 26.4 (6.5) 
Substance dependence            
 Alcohol dependence 8 15.3 (5.1) 3.7 (2.7) 6.1 (3.4) 5.5 (3.3)  4 18.4 (8.1) 14.6 (7.4) 3.8 (4.0) 0.0 (0.0) 
 Drug dependence 18 25.5 (5.2) 6.6 (2.9) 4.0 (2.3) 14.9 (4.2)  13 37.5 (8.2) 21.0 (6.9) 2.8 (2.8) 13.6 (5.8) 
 Any substance dependence 23 20.3 (3.8) 4.9 (2.1) 3.3 (1.7) 12.0 (3.1)  17 30.0 (6.2) 17.8 (5.2) 3.4 (2.5) 8.7 (3.8) 
Total            
 Any disorder 328 48.3 (1.9) 2.1 (0.5) 9.1 (1.1) 37.2 (1.9)  87 27.6 (2.5) 9.2 (1.6) 1.9 (0.8) 16.5 (2.1) a Weighted by sex, Child Behavior Checklist cut-offs (normal vs borderline clinical/clinical) and parental socioeconomic position. Cases with missing values were assigned the weight 1. 
b Initial treatment contact for any health care professional based on the Composite International Diagnostic Interview. 
c Initial treatment contact for secondary mental health care based on the Psychiatric Case Register North Netherlands. Adolescents with any disorder onset before 2000 were excluded because 
register data were not available before 2000. 
 




Table 2. Cox regression analyses predicting time-to-treatmenta with any health care professionalb for DSM-IV disorders by disorder class and any disorder 
 Any health care professionalb 
 Mood disorders  Anxiety disorders  Behavior disorders  Substance dependence  Any disorder 
 HR (95%CI)  HR (95%CI)  HR (95%CI)  HR (95%CI)  HR (95%CI) 
Male (ref=female) 0.74 (0.51-1.06)  0.90 (0.61-1.31)  1.64 (0.97-2.77)  0.96 (0.39-2.36)  0.88 (0.69-1.13) 
Ethnic minority (ref=majority) 1.01 (0.61-1.69)  0.50 (0.24-1.01)  0.82 (0.29-2.27)  ‒h  0.90 (0.59-1.36) 
Low IQ (ref=high) 1.46 (0.74-2.85)  1.72 (0.88-3.39)  1.52 (0.51-4.53)  3.27 (0.58-18.43)  1.37 (0.85-2.21) 
Middle IQ (ref=high) 1.29 (0.74-2.23)  1.36 (0.77-2.40)  1.73 (0.67-4.48)  1.74 (0.37-8.20)  1.31 (0.88-1.93) 
Low parental SEP (ref=high) 1.20 (0.74-1.94)  1.08 (0.64-1.80)  1.02 (0.53-1.98)  1.31 (0.42-4.10)  1.27 (0.91-1.77) 
Middle parental SEP (ref=high) 1.39 (0.94-2.06)  1.04 (0.69-1.58)  0.64 (0.34-1.18)  1.30 (0.46-3.70)  1.18 (0.90-1.57) 
0 or 1 biological parents (ref=both) 0.97 (0.68-1.37)  1.32 (0.93-1.88)  1.03 (0.61-1.75)  0.94 (0.36-2.45)  1.28* (1.00-1.62) 
Severe disorder (ref=mild)c 1.73*** (1.26-2.36)  1.94*** (1.33-2.85)  1.98** (1.19-3.29)  ‒c  1.57*** (1.22-2.03) 
Age at onset 1-5 (ref=16-20) ‒e  0.15*** (0.07-0.32)  0.67 (0.35-1.30)  ‒h  0.20*** (0.12-0.32) 
Age at onset 6-10 (ref=16-20) 0.38** (0.20-0.73)  0.23*** (0.11-0.47)  0.41** (0.21-0.80)  ‒i  0.26*** (0.17-0.42) 
Age at onset 11-15 (ref=16-20) 0.79 (0.55-1.13)  0.48* (0.24-0.93)  ‒g  1.78 (0.73-4.32)  0.58** (0.39-0.87) 
Co-morbid mood disorder (ref=no)d ‒f  2.79*** (1.90-4.09)  1.82 (0.93-3.56)  2.43 (0.98-6.03)  3.09*** (2.35-4.06) 
Co-morbid anxiety disorder (ref=no)d 1.01 (0.73-1.39)  ‒f  0.88 (0.53-1.49)  2.43 (0.98-6.03)  1.09 (0.83-1.42) 
Co-morbid behavior disorder (ref=no)d 0.85 (0.57-1.29)  1.49 (0.98-2.25)  ‒f  0.60 (0.22-1.60)  1.49** (1.11-2.01) 
Co-morbid substance dependence (ref=no)d 1.91* (1.12-3.27)  0.81 (0.38-1.73)  1.04 (0.35-3.09)  ‒f  1.06 (0.65-1.73) 
Chi-square 36.3 (13)***  125.9 (14)***  24.9 (13)*  14.9 (10)  276.2 (15)*** 
n events 172  145  72  23  314 
n censored 96  284  93  86  347 
n total 268  429  165  109  661 
DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, fourth edition; HR = Hazard ratio; 95%CI = 95% confidence interval; IQ = intelligence quotient; SEP = socio-economic position 
a Time-to-treatment for disorders with initial treatment contact after initial symptoms and before the year of onset of the respective full-blown disorder set to 0. 
b Lifetime treatment contact and age of initial treatment contact for any health care professional based on the Composite International Diagnostic Interview. 
c All substance dependence diagnoses were considered severe. 
d Time-dependent covariate. 
e Combined with age of onset 6-10 years due to insufficient cases. 
f Disorder class is the dependent variable. 
g Combined with age of onset 16-20 years (reference category) due to insufficient cases in the reference category. 
h Covariate excluded due to insufficient cases. 
i Combined with age of onset 11-15 years due to insufficient cases. 
* p<.05   ** p<.01   *** p<.001 
 




Table 3. Cox regression analyses predicting time-to-treatmenta with secondary mental health careb for DSM-IV disorders by disorder class and any disorder for adolescents without any disorder 
onset before 2000 
 Secondary mental health careb 
 Mood disorders  Anxiety disorders  Behavior disorders  Substance dependence  Any disorder 
 HR (95%CI)  HR (95%CI)  HR (95%CI)  HR (95%CI)  HR (95%CI) 
Male (ref=female) 1.31 (0.66-2.63)  0.73 (0.33-1.62)  1.54 (0.35-6.73)  1.81 (0.49-6.76)  1.09 (0.67-1.77) 
Ethnic minority (ref=majority) 0.53 (0.15-1.91)  ‒h  23.12* (1.32-403.92)  ‒h  0.89 (0.35-2.30) 
Low IQ (ref=high) 1.84 (0.59-5.74)  1.12 (0.38-3.29)  1.19 (0.17-8.17)  0.90 (0.12-6.78)  1.81 (0.77-4.25) 
Middle IQ (ref=high) 1.15 (0.43-3.05)  0.96 (0.38-2.40)  0.51 (0.09-2.75)  0.47 (0.10-2.13)  1.12 (0.55-2.29) 
Low parental SEP (ref=high) 1.71 (0.65-4.48)  3.08 (0.98-9.70)  6.82 (0.69-67.49)  3.32 (0.63-17.45)  1.66 (0.81-3.41) 
Middle parental SEP (ref=high) 2.09 (0.96-4.53)  3.49* (1.25-9.74)  5.49 (0.59-51.45)  1.47 (0.39-5.53)  1.85* (1.03-3.32) 
0 or 1 biological parents (ref=both) 1.50 (0.78-2.90)  1.54 (0.78-3.05)  1.55 (0.40-5.99)  0.61 (0.18-2.14)  1.42 (0.88-2.28) 
Severe disorder (ref=mild)c 1.39 (0.78-2.50)  1.44 (0.69-3.03)  0.70 (0.21-2.38)  ‒c  1.20 (0.71-2.02) 
Age at onset 1-5 (ref=16-20) ‒e  ‒e  ‒e  ‒e  ‒e 
Age at onset 6-10 (ref=16-20) 0.17 (0.02-1.33)  0.41 (0.12-1.45)  0.54 (0.11-2.59)  ‒i  0.34** (0.15-0.77) 
Age at onset 11-15 (ref=16-20) 0.71 (0.37-1.37)  0.54 (0.20-1.47)  ‒g  0.54 (0.13-2.30)  0.58 (0.31-1.09) 
Co-morbid mood disorder (ref=no)d ‒f  4.30*** (2.23-8.28)  1.65 (0.38-7.04)  2.35 (0.72-7.60)  2.13** (1.24-3.67) 
Co-morbid anxiety disorder (ref=no)d 1.82 (0.99-3.33)  ‒f  1.09 (0.29-4.06)  1.60 (0.45-5.67)  1.18 (0.69-2.04) 
Co-morbid behavior disorder (ref=no)d 1.54 (0.65-3.67)  1.54 (0.63-3.75)  ‒f  2.15 (0.60-7.70)  1.60 (0.79-3.23) 
Co-morbid substance dependence (ref=no)d 1.63 (0.59-4.47)  1.89 (0.64-5.59)  1.31 (0.17-10.12)  ‒f  1.40 (0.62-3.14) 
Chi-square 20.3 (13)  63.1 (12)***  14.9 (12)  10.0 (10)  41.3 (14)*** 
n events 50  44  17  16  83 
n censored 89  117  27  37  216 
n total 139  161  44  53  299 
DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, fourth edition; HR = Hazard ratio; 95%CI = 95% confidence interval; IQ = intelligence quotient; SEP = socio-economic position 
a Time-to-treatment for disorders with initial treatment contact before the year of onset of the respective disorder set to 0. 
b Lifetime treatment contact and age of initial treatment contact for secondary mental health care based on the Psychiatric Case Register North Netherlands. 
c All substance dependence diagnoses were considered severe. 
d Time-dependent covariate. 
e No cases, because adolescents with any disorder onset before 2000 were excluded. 
f Disorder class is the dependent variable. 
g Combined with age of onset 16-20 years (reference category) due to insufficient cases in the reference category. 
h Covariate excluded due to insufficient cases. 
i Combined with age of onset 11-15 years due to insufficient cases. 
* p<.05   ** p<.01   *** p<.001 
 





Figure 1. Weighted cumulative lifetime treatment probabilities with any health care professional for 
DSM-IV mood disorders (A), anxiety disorders (B), behavior disorders (C), and substance dependence 
(D). 
Notes. Weighted by sex, Child Behavior Checklist cut-offs (normal v. borderline clinical/clinical) and 
parental SEP. Cases with missing values were assigned the weight 1. Probabilities based on life tables 
using the Actuarial method. Time-to-treatment for disorders with initial treatment contact after 
initial symptoms and before the year of onset of the respective full-blown disorder set to 0. DYS: 
dysthymia; MDD: major depressive disorder; BPD: bipolar disorder types I and II; PDS: panic disorder; 
GAD: generalized anxiety disorder; AGP: agoraphobia; OCD: obsessive-compulsive disorder; SO: 
social phobia; SAD: separation anxiety disorder; SP: specific phobia; ADD: attention deficit 
hyperactivity disorder; ODD: oppositional defiant disorder; DRD: drug dependence; ALD: alcohol 
dependence. 
 




Appendix Table 1. Cox regression analyses predicting time-to-treatmenta with any health care professionalb for DSM-IV disorders by disorder class and any disorder for adolescents without any 
disorder onset before 2000 
 Any health care professionalb 
 Mood disorders  Anxiety disorders  Behavior disorders  Substance dependence  Any disorder 
 HR (95%CI)  HR (95%CI)  HR (95%CI)  HR (95%CI)  HR (95%CI) 
Male (ref=female) 0.81 (0.5-1.31)  0.65 (0.34-1.25)  1.33 (0.47-3.80)  0.71 (0.17-2.95)  0.72 (0.50-1.03) 
Ethnic minority (ref=majority) 1.28 (0.67-2.42)  0.72 (0.26-2.01)  1.05 (0.14-7.66)  ‒h  1.14 (0.68-1.92) 
Low IQ (ref=high) 1.60 (0.72-3.57)  3.56* (1.18-10.78)  0.72 (0.12-4.18)  4.51 (0.52-39.46)  1.63 (0.83-3.20) 
Middle IQ (ref=high) 0.94 (0.49-1.8)  1.90 (0.74-4.91)  0.40 (0.10-1.52)  0.58 (0.10-3.27)  1.21 (0.70-2.09) 
Low parental SEP (ref=high) 1.14 (0.61-2.13)  0.79 (0.35-1.76)  0.83 (0.23-2.99)  0.22 (0.02-2.86)  1.17 (0.73-1.89) 
Middle parental SEP (ref=high) 1.32 (0.81-2.15)  1.00 (0.53-1.91)  0.31 (0.07-1.29)  0.94 (0.21-4.17)  1.11 (0.76-1.64) 
0 or 1 biological parents (ref=both) 1.06 (0.67-1.69)  0.89 (0.46-1.7)  0.81 (0.23-2.78)  0.28 (0.05-1.61)  1.08 (0.76-1.55) 
Severe disorder (ref=mild)c 1.98*** (1.33-2.96)  1.15 (0.60-2.19)  2.45 (0.82-7.29)  ‒c  1.03 (0.71-1.50) 
Age at onset 1-5 (ref=16-20) ‒e  ‒e  ‒e  ‒e  ‒e 
Age at onset 6-10 (ref=16-20) 0.49 (0.19-1.24)  0.28* (0.10-0.81)  0.53 (0.13-2.12)  ‒i  0.31*** (0.18-0.56) 
Age at onset 11-15 (ref=16-20) 0.78 (0.50-1.22)  0.58 (0.27-1.25)  ‒g  3.21 (0.87-11.86)  0.53** (0.35-0.81) 
Co-morbid mood disorder (ref=no)d ‒f  3.53*** (2.07-6.02)  1.87 (0.60-5.86)  5.87* (1.34-25.78)  2.74*** (1.86-4.04) 
Co-morbid anxiety disorder (ref=no)d 1.12 (0.73-1.72)  ‒f  ‒h  2.27 (0.62-8.33)  1.17 (0.78-1.73) 
Co-morbid behavior disorder (ref=no)d 1.04 (0.51-2.12)  1.91 (0.84-4.31)  ‒f  1.02 (0.17-5.97)  2.02** (1.19-3.42) 
Co-morbid substance dependence (ref=no)d 1.82 (0.91-3.63)  0.72 (0.23-2.26)  1.76 (0.30-10.52)  ‒f  1.35 (0.73-2.49) 
Chi-square 25.9 (13)*  56.3 (13)***  11.1 (11)  15.6 (10)  86.2 (14)*** 
n events 108  63  22  12  163 
n censored 63  128  30  57  201 
n total 171  191  52  69  364 
DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, fourth edition; HR = Hazard ratio; 95%CI = 95% confidence interval; IQ = intelligence quotient; SEP = socio-economic position 
a Time-to-treatment for disorders with initial treatment contact after initial symptoms and before the year of onset of the respective full-blown disorder set to 0. 
b Lifetime treatment contact and age of initial treatment contact for any health care professional based on the Composite International Diagnostic Interview. 
c All substance dependence diagnoses were considered severe. 
d Time-dependent covariate. 
e No cases, because adolescents with any disorder onset before 2000 were excluded. 
f Disorder class is the dependent variable. 
g Combined with age of onset 16-20 years (reference category) due to insufficient cases in the reference category. 
h Covariate excluded due to insufficient cases. 
i Combined with age of onset 11-15 years due to insufficient cases. 
* p<.05   ** p<.01   *** p<.001 
 




Appendix Table 2. Cox regression analyses predicting time-to-treatmenta with any health care professionalb for any symptom by disorder class and any disorder 
 Any health care professionalb 
 Mood disorders  Anxiety disorders  Behavior disorders  Substance dependence  Any disorder 
 HR (95%CI)  HR (95%CI)  HR (95%CI)  HR (95%CI)  HR (95%CI) 
Male (ref=female) 0.82 (0.58-1.17)  0.80 (0.58-1.11)  1.07 (0.70-1.64)  0.89 (0.49-1.59)  0.88 (0.69-1.13) 
Ethnic minority (ref=majority) 1.02 (0.64-1.64)  0.62 (0.34-1.12)  0.72 (0.30-1.72)  ‒h  0.90 (0.59-1.36) 
Low IQ (ref=high) 1.33 (0.72-2.46)  1.11 (0.63-1.99)  1.18 (0.46-2.98)  0.70 (0.25-1.93)  1.37 (0.85-2.21) 
Middle IQ (ref=high) 1.07 (0.65-1.77)  1.29 (0.80-2.08)  1.52 (0.67-3.41)  0.83 (0.37-1.88)  1.31 (0.88-1.93) 
Low parental SEP (ref=high) 1.32 (0.84-2.09)  1.18 (0.76-1.82)  1.22 (0.68-2.19)  1.65 (0.81-3.36)  1.27 (0.91-1.77) 
Middle parental SEP (ref=high) 1.36 (0.93-1.98)  1.20 (0.83-1.72)  0.84 (0.49-1.45)  1.23 (0.63-2.40)  1.18 (0.90-1.57) 
0 or 1 biological parents (ref=both) 1.00 (0.73-1.38)  1.41* (1.04-1.91)  1.23 (0.78-1.93)  1.53 (0.86-2.72)  1.28* (1.00-1.62) 
Severe disorder (ref=mild)c 1.61** (1.20-2.17)  1.51* (1.07-2.14)  1.38 (0.90-2.13)  ‒c  1.57*** (1.22-2.03) 
Age at onset 1-5 (ref=16-20) ‒e  0.22*** (0.11-0.44)  0.54* (0.29-0.97)  ‒i  0.20*** (0.12-0.32) 
Age at onset 6-10 (ref=16-20) 0.40** (0.22-0.73)  0.35** (0.18-0.68)  0.42** (0.23-0.74)  ‒j  0.26*** (0.17-0.42) 
Age at onset 11-15 (ref=16-20) 0.80 (0.58-1.13)  0.59 (0.32-1.09)  ‒g  1.00 (0.55-1.85)  0.58** (0.39-0.87) 
Co-morbid mood disorder (ref=no)d ‒f  4.97*** (3.65-6.79)  2.94*** (1.81-4.78)  2.58** (1.45-4.59)  3.09*** (2.35-4.06) 
Co-morbid anxiety disorder (ref=no)d 1.18 (0.87-1.61)  ‒f  1.59* (1.05-2.41)  1.48 (0.84-2.62)  1.09 (0.83-1.42) 
Co-morbid behavior disorder (ref=no)d 1.23 (0.84-1.79)  2.17*** (1.53-3.06)  ‒f  1.90* (1.08-3.35)  1.49** (1.11-2.01) 
Co-morbid substance dependence (ref=no)d 1.68 (0.99-2.87)  1.32 (0.73-2.40)  1.37 (0.56-3.35)  ‒f  1.06 (0.65-1.73) 
Chi-square 36.7 (13)***  310.3 (14)***  62.0 (13)***  29.4 (10)**  276.2 (15)*** 
n events 190  199  99  56  314 
n censored 78  234  69  53  347 
n total 268  433  168  109  661 
DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, fourth edition; HR = Hazard ratio; 95%CI = 95% confidence interval; IQ = intelligence quotient; SEP = socio-economic position 
a Time-to-treatment for disorders with initial treatment contact after initial symptoms and before the year of onset of the respective full-blown disorder set to 0. 
b Lifetime treatment contact and age of initial treatment contact for any health care professional based on the Composite International Diagnostic Interview. 
c All substance dependence diagnoses were considered severe. 
d Time-dependent covariate. 
e Combined with age of onset 6-10 years due to insufficient cases. 
f Disorder class is the dependent variable. 
g Combined with age of onset 16-20 years (reference category) due to insufficient cases in the reference category. 
h Covariate excluded due to insufficient cases. 
i Combined with age of onset 11-15 years due to insufficient cases. 
* p<.05   ** p<.01   *** p<.001 
 
